Subscribe: Market Wire - Medical and Healthcare: Alternative
http://img.marketwire.com/rss/mwMHAL.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
agreement  announces  company  jan  january  marketwired jan  marketwired january  marketwired  medical  new  otc pink  otc 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Alternative

Marketwired - Alternative



Marketwired - Alternative



Last Build Date: Mon, 23 Jan 2017 01:31:53 EST

Copyright: Copyright: (C) Marketwired
 



Diet Doc's New Sermorelin GHRP-2 Stimulates Weight Loss for Men and Women

Mon, 23 Jan 2017 01:00:00 EST

PHOENIX, AZ--(Marketwired - January 23, 2017) - Much safer than the controversial hCG diet, our new Sermorelin with an added peptide, GHRP-2 is a muscle enhancer and weight loss aid for both men and women who are looking to gain and preserve muscle mass, speed up their metabolisms and slow down the aging process. Sermorelin is a growth hormone that is known to promote the healthy function of the body's main human Growth Hormone (hGH). hGH has often be used for hormone replacement therapy treatments, but not without a range of adverse and often debilitating side effects. Sermorelin however, is considered to be a much safer alternative since it functions by stimulating the natural release of hGH within the body.




THC Restates Financial Statements to Show Reclassification of $250,000 from Income to Subscription Funds

Fri, 20 Jan 2017 19:07:40 EST

VANCOUVER, BC--(Marketwired - January 20, 2017) - THC BioMed Intl Ltd. ("THC" or the "Company") (CSE: THC) (CSE: THC.CN) (CNSX: THC) (OTCQB: THCBF) (FRANKFURT: TFHC) announces that due to a request from Trans-Medica Ltd. ("Trans-Medica") in September 2016, it agreed to re-categorize, from income to subscription funds, an amount of money that had previously been received by THC from Trans-Medica. As a result, THC will restate its annual financial statements for the year ended July 31, 2016 and the financial quarters ended April and October 2016. While the $250,000 was initially received by THC pursuant to an invoice for services rendered and categorized as income, Trans-Medica contacted THC in the fall of 2016 to say that it had intended the funds to be used as subscription funds for shares at $0.25 each. Since the written agreement between the parties -- previously announced in press releases filed on May 14, 2015 and July 15, 2015 -- had allowed for that possibility, THC agreed in September 2016 to convert the amount into shares at $0.25. That price was available to the Issuer for the issuance of shares pursuant to CSE policy at the time. As a result, the Issuer will restate its financial statements to reflect that the money received was for subscription funds received in advance and not regular income.




THC BioMed Begins Shipping Live Cannabis Plants across Canada to ACMPR Registered Patients and Announces Wholesale Genetic Pricing

Fri, 20 Jan 2017 19:06:45 EST

VANCOUVER, BC--(Marketwired - January 20, 2017) - THC BioMed Intl Ltd. ("THC" or the "Company") (CSE: THC) (CSE: THC.CN) (CNSX: THC) (OTCQB: THCBF) (FRANKFURT: TFHC) is pleased to announce that it has begun shipping live cannabis plants to patients registered under the ACMPR.




Ubiquitech Software Corp. Announces Earnings Release Date and First Shareholder Conference Call

Fri, 20 Jan 2017 12:36:54 EST

DENVER, CO--(Marketwired - Jan 20, 2017) - Ubiquitech Software Corp. (OTC PINK: UBQU) is pleased to announce that it will be releasing earnings results on Thursday, January 26th. Following the close of market the company will also be holding an investor conference call at 4:30PM EST.




NutraFuels, Inc. (NTFU) Appoints Mr. Daniel Slane to the Company's Advisory Board and Engages the Services of The Slane Company LLC. to Spearhead the Company's Expansion into Several Key International Markets

Fri, 20 Jan 2017 09:16:48 EST

COCONUT CREEK, FL--(Marketwired - January 20, 2017) - NutraFuels, Inc. ("NutraFuels" or "NTFU") (OTC PINK: NTFU) today announced that the company has engaged the services of Mr. Daniel Slane of The Slane Company LLC., to spearhead and advise on various expansion opportunities into several key international markets including Europe, Asia, India and Africa.




Servier Appoints MaSTherCell for the Development of its CAR-T Cell Therapy Manufacturing Platform

Fri, 20 Jan 2017 09:00:00 EST

GERMANTOWN, MD--(Marketwired - Jan 20, 2017) -   Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that its wholly-owned subsidiary, MaSTherCell S.A., specializing in the delivery of optimized process industrialization capacities to cell therapy organizations, has signed a master service agreement with Servier for the development of a manufacturing platform for allogeneic cell therapies. Under the master service agreement, MaSTherCell is developing a CAR-T cell therapy manufacturing platform, which will enable industrial and commercial manufacturing of Servier's cell therapy products. This is a critical step in the development of these products for later stage clinical trials.




Rennova Health's Pharmacogenomics Subsidiary Granted Patent

Fri, 20 Jan 2017 08:30:00 EST

WEST PALM BEACH, FL--(Marketwired - January 20, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that its Genomas, Inc. pharmacogenomics subsidiary has been granted a Patent by the US Patent and Trademark Office.




The Chief Scientist of Biotech Precision Berhad Has Signed Collaboration Agreement with SHOM

Fri, 20 Jan 2017 06:00:00 EST

NEW YORK, NY--(Marketwired - Jan 20, 2017) -  Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer of the healthcare industry, is announcing that Dr. Liu Zhongzheng, the chief scientist and medical advisor of Biotech Precision Berhad has signed a collaboration agreement with SHOM. Dr. Liu Zhongzheng has many achievements under his belt that allows him to direct and help the company succeed.




Dr. Nishant Rao Finds Evidence of Low-Reliability in hCG Drops

Fri, 20 Jan 2017 01:00:00 EST

PHOENIX, AZ--(Marketwired - January 20, 2017) - Many dieters are taking hCG (drops, tablets and injections) in addition to their Weight Watchers or other calorie counting diet programs this season to burn fat more rapidly. hCG (human chorionic gonadotropin) is the placental glycoprotein hormone whose levels rise during pregnancy. Used since the 1950s as a hormone treatment in conjunction with a very low calorie diet, hCG is purported to signal to the brain where excess fat is stored and enables its release from fatty areas of the body. Dr. Nishant Rao, Medical Director of the nationally recognized weight loss program, Diet Doc, has researched the effectiveness of hCG in its different forms and has found that injections of hCG drops may offer inconsistent results when compared to injections or tablets. "hCG drops come in two different forms: a prescription version and an over the counter homeopathic version. Both options are far inferior to hCG tablets or injections for the following reasons: the prescription drops are very poorly absorbed even though they are the actual prescription hormone, so most of the liquid ends up mixing with saliva and is swallowed." He continues, "hCG that is swallowed is deactivated and ineffective."




Cronos Applauds German Legalization of Medical Cannabis

Thu, 19 Jan 2017 16:10:41 EST

TORONTO, ON--(Marketwired - January 19, 2017) - PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or the "Company"), is pleased to announce that the German parliament has expanded its medical marijuana program. In a landmark bill, members of Germany's parliament voted unanimously to legalize the use of medical marijuana and have implemented a policy that will provide health insurance coverage for patients with an eligible prescription. The medical marijuana program and accompanying health insurance regulations will cover both dried cannabis flower, as well as cannabis extracts.




Asian Art Museum of San Francisco Unearths Stories of Life and the Afterlife in Early China

Thu, 19 Jan 2017 15:30:04 EST

SAN FRANCISCO, CA--(Marketwired - January 19, 2017) - Like the Roman Empire, China's Han dynasty (206 BCE-220 CE) forged one of the most powerful, advanced civilizations of the ancient world, and its elite had it all: unbridled luxury, technical innovations and courtly romance. On February 17 the Asian Art Museum unveils Tomb Treasures: New Discoveries from China's Han Dynasty, an original exhibition of more than 160 intriguing works recently unearthed from the coastal heartland of classical Chinese culture.




Newly Created Standards Coordinating Body Seeks to Advance Development and Establishment of Regenerative Medicine Standards

Thu, 19 Jan 2017 15:23:19 EST

Builds upon call for standards development in 21st Century Cures Act




The Alliance for Regenerative Medicine Launches Standards Coordinating Body to Advance Development and Establishment of Industry-Wide Standards

Thu, 19 Jan 2017 12:22:41 EST

Builds upon call for standards development in 21st Century Cures Act




UPDATE - Greenhouse Solutions, Inc. Issues Company Update

Thu, 19 Jan 2017 12:05:47 EST

GREENWOOD VILLAGE, CO--(Marketwired - Jan 19, 2017) -  Greenhouse Solutions, Inc. (OTC PINK: GRSU) ("GH Solutions"), a company focused on creating and offering nutritional products with hemp supplements, is pleased to provide a Distributor Update and news on a distribution improvement that is being implemeted to the KOIOS Raspberry Wonder with Hemp beverage.




Kirkman(R) Adds A Powerful Enzyme Product to Its Line of Microbiome Products

Thu, 19 Jan 2017 10:00:00 EST

PORTLAND, OR--(Marketwired - January 19, 2017) - Kirkman® nutraceutical company in Portland, OR, has added another product to its new line of microbiome supporting products. Microbiome Broad Spectrum Enzyme w/DPP-IVT is a proprietary formulation that provides broad-spectrum enzymatic activity to support microbiome health.




Amedica Announces Pricing of Public Offering to Raise $4.5 Million

Thu, 19 Jan 2017 09:46:33 EST

SALT LAKE CITY, UT--(Marketwired - Jan 19, 2017) -  Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced the pricing of an underwritten public offering of common stock and warrants with a public offering price of $0.51 for one share of common stock and 0.45 warrants. Each whole warrant is exercisable for one share of common stock. The Company expects to receive gross proceeds of approximately $4.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses. The Company has also granted a 45-day option to the underwriters to purchase up to an additional 15% of the shares of common stock plus up to 15% of the warrants; provided that in no event may the aggregate market value of securities sold in the offering, including from the over-allotment option, exceed the limitations set forth in Rule I.B.6 of Form S-3 solely to cover over-allotments, if any.







Vaxil Bio Expands Into Infectious Diseases With First US Patent for MTbuVax(TM)

Thu, 19 Jan 2017 09:30:00 EST

Receives USPTO Notice of Allowance for MTbuVax(TM) Family of Signal Peptide Vaccines and their use in Treating Major Infectious Diseases




Invictus MD Strategies Outlines Vision in Exclusive Interview with CFN

Thu, 19 Jan 2017 09:15:00 EST

SEATTLE, WA--(Marketwired - Jan 19, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article and interview discussing recent developments and the path forward for Invictus MD Strategies Inc. (CSE: IMH) (OTC PINK: IVITF).




Abattis Explores Diversifying with a Strategic Acquisition -- CFN Media

Thu, 19 Jan 2017 09:15:00 EST

SEATTLE, WA--(Marketwired - Jan 19, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (OTC PINK: ATTBF) (CNSX: ATT), a specialty agricultural technology firm focused on the legal cannabis industry. The company recently commissioned an independent valuation on Green Nature Health Care Products Inc. in advance of a potential strategic acquisition. The move would follow the company's international licensing and co-branding agreement signed in November of last year and Green Nature's strong financial performance since then.




InMed Pharma Appoints Eli Lilly Finance Executive to Board of Directors -- CFN Media

Thu, 19 Jan 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Jan 19, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing InMed Pharmaceuticals Inc.'s (OTCQB: IMLFF) (CNSX: IN) recent appointment of Martin Bott to its Board of Directors, the company's existing team, and what it means as InMed progresses towards its first clinical trial in INM-750 for the treatment of Epidermolysis Bullosa as well as the rest of its clinical pipeline.




AXIM Biotech Begins CanChew Plus Clinical Trials -- SECFilings.com

Thu, 19 Jan 2017 09:00:00 EST

REDONDO BEACH, CA--(Marketwired - Jan 19, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering AXIM® Biotechnologies Inc.'s (OTCQB: AXIM) recently announced clinical trials evaluating its CanChew Plus® cannabidiol (CBD) gum for the treatment of irritable bowel syndrome (IBS).




H-Source Announces A Co-Marketing Plan With Colorado Hospital Association

Thu, 19 Jan 2017 09:00:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 19, 2017) - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce that it has entered into a joint marketing agreement with the Colorado Hospital Association ("CHA"). It is expected to benefit the hospitals of Colorado. The H-Source platform will provide CHA hospital members a private cloud-based marketplace to purchase and sell inventory providing great cost savings and convenience. Additionally, CHA members will have access to the complete H-Source marketplace of member facilities across the U.S.




NeutriSci Announces Successful Development and Positive Results From Initial Observational Product Trials With Lexaria Bioscience

Thu, 19 Jan 2017 08:00:00 EST

VANCOUVER, BC--(Marketwired - January 19, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) and Lexaria Bioscience Corp. ("Lexaria") (CSE: LXX) are pleased to announce the successful development and initial trial of the industry's first cannabinoid / pterostilbene edible tablet utilizing NeutriSci's and Lexaria's proprietary and patented technologies.




Golden Leaf to Present on Cannabis Investor Webcast on January 26, 2017

Thu, 19 Jan 2017 08:00:00 EST

TORONTO, ON--(Marketwired - January 19, 2017) - Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE: GLH) (OTCQB: GLDFF), a leading cannabis oil solutions company built around recognized brands, is pleased to announce that it will be a presenting company on the upcoming Cannabis Investor Webcast. The Webcast is scheduled to take place on Thursday, January 26, and GLH is scheduled to present from 2pm ET to 2:45pm ET.




Nutritional High Announces Inclusion Into U.S. Marijuana Index

Thu, 19 Jan 2017 07:30:00 EST

TORONTO, ONTARIO--(Marketwired - Jan. 19, 2017) - Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT)(CSE:EAT.CN)(OTCQB:SPLIF)(FRANKFURT:2NU) is pleased to announce that it has been added to the U.S. Marijuana Index.




Two Rivers Properties Begin Rent Revenue

Thu, 19 Jan 2017 07:00:00 EST

Two Rivers to Re-emphasize Development of Water Assets




Proto Script Pharmaceutical Corp. Building New Partnerships with Independent Practice Associations (IPA)

Thu, 19 Jan 2017 06:00:00 EST

RANCHO CUCAMONGA, CA--(Marketwired - Jan 19, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, today provided this update regarding its current business and future expansion plans with Independent Practice Associations.




NC Industrial Hemp Commission Set to Finalize Proposed Rules and Regulations on Growing Industrial Hemp in North Carolina

Thu, 19 Jan 2017 05:00:00 EST

SPRING HOPE, NC--(Marketwired - Jan 19, 2017) - Hemp, Inc. (OTC PINK: HEMP) executives are pleased to report that the North Carolina Industrial Hemp Commission (NCIHC) is only a few weeks away from finalizing the rules and regulations on the cultivation of hemp in North Carolina since it last convened on December 22, 2016. According to the article NC Nears Finalizing Rules Regarding the Growing of Hemp, published 1/12/17 on wncn.com, "about 80 people interested in the hemp industry attended a public forum to comment on the proposed rules" last week. The commission will accept written comments about the rules through January 27, 2017 and hopes to finalize the rules and regulations next month. (Licenses could be issued as soon as spring.) Once finalized, the Commission will be able to accept applications and issue permits for people to grow hemp as part of the state's pilot program.




Diet Doc Offers Safer Weight Loss Alternatives For The hCG Diet Than Starvation-Based Simeons Method

Thu, 19 Jan 2017 01:00:00 EST

PHOENIX, AZ--(Marketwired - January 19, 2017) - The hCG diet has, historically, been controversial because of its application within the Simeons diet. Despite being associated with dramatic weight loss of up to a pound per day, the hCG diet wasn't very well understood until recently. The original hCG diet, or Simeons diet, involved combining low doses of hCG (human chorionic gonadotropin), a hormone produced during pregnancy, with extremely low caloric intake to promote rapid weight loss by burning "abnormal" fat, located in cells and around internal organs. In theory, hCG accumulates in the hypothalamus, sends a signal to areas with excess fat storage, and makes fat loss possible. That original hCG formula, however, is seriously dangerous because it is essentially a starvation diet that caps daily consumption to 500 calories. It leads to harmful side effects like weakness, muscle loss, and hair loss. The Obesity Medicine Association has highlighted the dangers of the hCG-based Simeons method, marking it as unsafe and not recommended.




Amedica Announces Proposed Public Offering of Common Stock and Warrants

Wed, 18 Jan 2017 16:01:00 EST

SALT LAKE CITY, UT--(Marketwired - Jan 18, 2017) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced that it intends to offer and sell common stock and warrants, subject to market and other conditions, in an underwritten public offering. The common stock and warrants are being offered under the Company's effective shelf registration statement previously filed with the Securities and Exchange Commission (SEC). Net proceeds from the offering will be used by Amedica to (1) remain in compliance with the financial covenants in its outstanding Loan and Security Agreement; (2) support working capital needs and other general corporate purposes; (3) fund research and development and commercialization activities of Amedica's product candidates, including the funding of clinical trials Amedica plans to conduct for its product candidates; and (4) continue to build sales, marketing and distribution capabilities for Amedica's silicon nitride technology platform and other products, including the costs of inventory and instruments.




PHZIO Telehealth Webinar Link

Wed, 18 Jan 2017 13:30:36 EST

CULVER CITY, CA--(Marketwired - Jan 18, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company successfully held its initial webinar this morning. Please see the following link to view this webinar: https://wnarchives.s3.amazonaws.com/45426582/62c11c14-baa2-4ad7-b8cd-521b38fd3542/archive.mp4. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com




Megadyne Medical Named Utah's Most Innovative PR & Marketing Team 2016

Wed, 18 Jan 2017 13:00:00 EST

DRAPER, UT--(Marketwired - January 18, 2017) - Megadyne Medical Products, The Electrosurgical Authority® and full-solution electrosurgical provider, was recently named Utah's Most Innovative PR & Marketing Team 2016 by Corporate America News magazine. According to the online publication based in New York City, this prestigious award was granted to the medical device company based on its impressive presence across media, as well as client recommendations and referrals from other agencies who have witnessed the impact of Megadyne through its various PR and marketing initiatives.




American Green Leverages App Platform

Wed, 18 Jan 2017 10:22:31 EST

Gathers Market Insights for Future Revenue Streams




Premier Biomedical Pain Management Solutions Announces Product Distribution Agreement of Their Superior Pain Relief Products

Wed, 18 Jan 2017 10:15:00 EST

EL PASO, TX--(Marketwired - Jan 18, 2017) - Premier Biomedical, Inc. (OTCQB: BIEI) announced today their newly created joint venture company, Premier Biomedical Pain Management Solutions, LLC (PBPMS) has signed a distribution agreement contract with the Pain Relief & Wellness Strategy Center in Grove City, Pennsylvania to sell and distribute its pain relief products. Initially, the contract will cover pain relief patches and roll-ons, but will expand as new products are introduced.







Medical Marijuana Secures Partnership with Key Pharmaceutical Distributor -- CFN Media

Wed, 18 Jan 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Jan 18, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical Marijuana Inc.'s (OTC PINK: MJNA) recent groundbreaking agreement with a South American pharmaceutical distributor and how the company aims to capitalize on the market.




VPR Brands, LP will be Re-Launching the STINGER at the BIG Industry in Los Angeles California

Wed, 18 Jan 2017 08:30:00 EST

FORT LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - VPR Brands, LP (OTC PINK: VPRB) is proud to announce its participation in the 2017 Big Industry Show in Los Angeles, California on January 19-20th where we will be showcasing our flagship product, the STINGER, part of our Honey Stick Brand.




MTBC in 2016 -- An Exciting Year in Review

Wed, 18 Jan 2017 08:30:00 EST

A recollection of important corporate highlights




Temkin Ratings Now Available in the MaritzCX Customer Experience Platform

Wed, 18 Jan 2017 08:15:00 EST

MaritzCX Users Can Access Six Years of Global CX Benchmarking Data Across 20 Key Industries




NuGene International Initiates Targeted Launch of REVELLUS(TM) Hair Fortifying Serum

Wed, 18 Jan 2017 08:00:00 EST

Newly Improved Formulation Leverages NuGene's Proprietary Stem Cell Technology




Vinergy Resources/MJ Biopharma Appoint Scientific Advisory Board Chair to Pursue Clinical Testing of Cannabinoids for Therapeutics

Wed, 18 Jan 2017 08:00:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 18, 2017) - Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE:VIN)(CSE:VIN.CN) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that it has appointed Dr. William Panenka, MD as Chair of the Company's Scientific Advisory Board (SAB). Bringing on the right human capital through strategic hires is an important part of the Company's strategy to develop, test and identify specific cannabinoid isolates for targeted therapeutic purposes.




MediXall Appoints Dr. Pedro A. Sanchez, D.O., to be its First Medical Director

Wed, 18 Jan 2017 07:30:00 EST

FT. LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) is pleased to announce the appointment of its first Medical Director, Dr. Pedro A. Sanchez, D.O. Dr. Sanchez is a graduate of Southeastern College of Osteopathic Medicine in Ft. Lauderdale, Florida, and served his residency at Wellington Regional Medical Center in Wellington, Florida. Dr. Sanchez is Board Certified by the American Osteopathic Board of Family Physicians, and has been a successful family practice physician for over 25 years.




HempLife Today Announces New Product Improvements For 2017, Aimed at Increasing Sales, Increased Product Awareness and Maintaining Customer Satisfaction

Wed, 18 Jan 2017 07:30:00 EST

DENVER, CO--(Marketwired - Jan 18, 2017) - Ubiquitech Software Corp. (OTC PINK: UBQU), with pending name and symbol change to Endo BioSciences Inc, and its subsidiary HempLife TodayT, is announcing its new CannzALLT CBD hemp product improvements for 2017 that company data shows will help increase new sales, and sales to existing customers, as well as maintaining high company standards of customer satisfaction. New product improvements will be phased in and available by February 15th.




Diet Doc Reveals The Crucial, But Often Ignored, Role of Blood Sugar in Effective Weight Loss

Wed, 18 Jan 2017 01:00:00 EST

SANTA FE, NM--(Marketwired - January 18, 2017) - For nearly 50 years, obesity rates have been rapidly rising in the U.S. Over a third of all American adults are now considered "obese" even though 77% of Americans are "trying to eat healthier" and 19% are 'actively dieting.' There is certainly no shortage of dietary programs available, as the weight loss market has grown to over $64 billion. With the surplus of fatty foods and sugar in the American diet, however, obesity rates may not decrease anytime soon. Well-regulated blood sugar, for instance, has no negative effect on one's health or ability to lose weight. When someone consumes more sugar than their body can handle for a period of time, however, they start developing problems related to their body's ability to process sugar. According to Dr. Nishant Rao, resident medical expert at Diet Doc, a nationally recognized weight loss center, this leads the 'fasting glucose' (the amount of sugar present in the blood stream away from eating) to go up and stay up. "Elevations in blood sugar not only can eventually lead to diabetes, but are also correlated with heart disease and obesity. This can start to happen because they body can only process or handle a certain amount of glucose before the body has to do something else with it and that is generally to store it as fat." The problem can even worsen if there is an issue of insulin resistance, where there is even less of the sugar to be processed normally, leading much more of it to end up as fat tissue.




Helix BioPharma Corp. Announces Voting Results from Its Annual and Special Meeting of Shareholders

Tue, 17 Jan 2017 17:05:00 EST

TORONTO, ONTARIO--(Marketwired - Jan. 17, 2017) - Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) ("Helix"), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced today the results of matters voted on at its annual and special meeting of shareholders held on January 17, 2017 (the "Meeting").




Ross' Gold(TM) and Rokin To Launch the New Gold Standard in Vape Pens

Tue, 17 Jan 2017 13:11:34 EST

Launch of the Ross Gold Special Edition Cyclone(TM) to Take Place at High Times Business Summit in Los Angeles Jan 19th to 20th 2017




Medifirst Solutions to Present Its Time Machine Laser in Morocco and Dubai

Tue, 17 Jan 2017 11:00:00 EST

FREEHOLD, NJ--(Marketwired - Jan 17, 2017) - MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst") would like to update shareholders regarding its previous announcement about international sales for its FDA cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.




CB Insights Reveals the AI 100 List At The Innovation Summit

Tue, 17 Jan 2017 11:00:00 EST

CloudMedx Inc Selected to the 2017 AI 100, Highlighting Advancements in Clinical AI Insights at All Points of Care




CORRECTION - Endexx Corporation

Tue, 17 Jan 2017 09:49:41 EST

CAVE CREEK, AZ--(Marketwired - Jan 17, 2017) - In the news release issued earlier today by Endexx Corporation (OTC PINK: EDXC), we are advised by the company the headline should read, "Endexx Engages Turner, Stone & Company as Auditor and Eilers Law Group to Prepare for Up Listing" rather than "Endexx Engages Turner, Stone & Company as Auditor and Eilers Law Group to Prepare for Up Listin" as originally issued. Complete corrected text follows.




Advantis Corp. Boosts Bottom Line, Reduces Debt

Tue, 17 Jan 2017 09:26:00 EST

NEWPORT BEACH, CA--(Marketwired - Jan 17, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it has settled into its new commercial space to meet surging demand of Amstercan, rosin presses, and other products. The company has also announced that it has reduced debt by $250,000.




GeoVax to Collaborate with Georgia State University on Development of Therapeutic Hepatitis B Vaccine

Tue, 17 Jan 2017 09:00:00 EST

Targeting Chronic Hepatitis B Infections Affecting More Than 240 Million People Worldwide




Human Touch(R) Launches New Website with Tools to Strengthen Brand Messaging, Educate Customers, and Increase Dealer Sales

Tue, 17 Jan 2017 09:00:00 EST

New Website Communicates Brand Messaging and Helps to Guide Customers through their Journey of Education, Selection, and Purchase of Human Touch Products




PHZIO Telehealth Clinic Orientation and On-boarding

Tue, 17 Jan 2017 09:00:00 EST

CULVER CITY, CA--(Marketwired - Jan 17, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company is pleased to announce that it has begun clinic orientation and on-boarding of selected PT's at Motion PT Group and our other previously announced PT clinic licensees. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com




Biotica Pharmaceuticals Announces Board of Advisors -- Distinguished Scientists to Help Shape Biotica's Future

Tue, 17 Jan 2017 08:30:00 EST

SARASOTA, FL--(Marketwired - Jan 17, 2017) - Biotica Pharmaceuticals Inc. (Biotica), a biopharmaceutical company, which engages in discovering, developing, and commercializing cannabinoid-based medicines for Neuropathic pain, Cancer, Alzheimer's, Parkinson's, Esophagitis, and Immune Enhancement, announces today that it has begun strengthening the company by the formation of its board of advisors. Biotica's newly formed Board of Advisors includes scientists with deep knowledge of Biochemistry, Molecular Genetics, Enzymes, Cell Biology and Protein Chemistry. They will help guide Biotica in shaping its strategy and defining the next generation of cannabinoid-based medicines. The advisory board is comprised of the following individuals:




NeutriSci Adds Sobeys & Safeway to Its List of Canadian Retailers

Tue, 17 Jan 2017 08:30:00 EST

VANCOUVER, BC--(Marketwired - January 17, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Sobeys and Safeway Canada.




Endexx Engages Turner, Stone & Company as Auditor and Eilers Law Group to Prepare for Up Listin

Tue, 17 Jan 2017 08:00:00 EST

CAVE CREEK, AZ--(Marketwired - Jan 17, 2017) - Endexx Corporation (OTC PINK: EDXC), a provider of innovative phyto-nutrient based food and nutritional products, today announced that it has engaged Turner, Stone & Company LLP and has initiated audits for its fiscal 2015 and 2016. The audit will bring current Endexx's financials for the past four years. In addition, Eilers Law Group will then file all SEC documents on behalf of Endexx to bring the company to fully audited status and in full compliance with the SEC.




Greenhouse Solutions, Inc. Issues Company Update

Tue, 17 Jan 2017 07:30:00 EST

GREENWOOD VILLAGE, CO--(Marketwired - Jan 17, 2017) - Greenhouse Solutions, Inc. (OTC PINK: GRSU) ("GH Solutions"), a company focused on creating and offering nutritional products with hemp supplements, is pleased to provide a Distributor Update and news on a distribution improvement that is being implemeted to the KOIOS Raspberry Wonder with Hemp beverage.




Nutritional High Announces Launch of New Website

Tue, 17 Jan 2017 07:30:00 EST

TORONTO, ONTARIO--(Marketwired - Jan. 17, 2017) - Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT)(CSE:EAT.CN)(OTCQB:SPLIF)(FRANKFURT:2NU) is pleased to announce the launch of its new and completely redesigned website www.nutritionalhigh.com. The revamped website provides quick and easy access to essential information that offers an understanding of the Nutritional High's vision as well as the milestones accomplished by Nutritional High.




Study Shows Improved Primary Adherence as high as 99% using InstyMeds Automated Direct-to-Patient Dispensers

Tue, 17 Jan 2017 07:00:00 EST

MINNEAPOLIS, MN--(Marketwired - Jan 17, 2017) - A 2017 study conducted at the University of Minnesota and published in the journal ClinicoEconomics and Outcomes Research found patients that have their medications dispensed at the point of care have much higher rates of adherence.




Proto Script Pharmaceutical Corp. discusses Opportunities in the Expanding US Power Wheelchair and Mobility Scooter Market

Tue, 17 Jan 2017 06:00:00 EST

RANCHO CUCAMONGA, CA--(Marketwired - Jan 17, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, is pleased to provide this discussion regarding opportunities in the expanding US power wheelchair and mobility scooter market.




Dr. Liu Zhongzheng as Chief Scientist and Medical Advisor of Biotech Precision Berhad

Tue, 17 Jan 2017 06:00:00 EST

NEW YORK, NY--(Marketwired - Jan 17, 2017) - Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer of the healthcare industry, is announcing that Dr. Liu Zhongzheng is the chief scientist and medical advisor of Biotech Precision Berhad, which has signed a collaboration agreement with SHOM. Dr. Liu has the drive and capacity to succeed and innovate, and has many achievements under his belt that help solidify his position within the company.




Rennova Health Completes Asset Purchase Agreement of Scott County Community Hospital

Tue, 17 Jan 2017 06:00:00 EST

WEST PALM BEACH, FL--(Marketwired - January 17, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that it has closed the previously reported Asset Purchase Agreement to acquire certain assets related to Scott County Community Hospital, based in Oneida, Tennessee ("Scott County Hospital").




Diet Doc Offers Comprehensive Sermorelin Therapy For Anti-Aging and Rapid Weight Loss

Tue, 17 Jan 2017 01:00:00 EST

MANCHESTER, NH--(Marketwired - January 17, 2017) - Old age leads to many undesirable changes that negatively affect organs, bodily functions, and weight regulation. Hormone production becomes, similarly, considerably decreased or ineffective altogether. On a gender-specific basis, aging leads males to gradually lose testosterone while females experience reduced estradiol and estrogen-related hormones, often during or after menopause. Many individuals experience sexual difficulties, muscle loss, lowered energy, and excessive weight gain are common as well. And while there is no permanent solution for aging, there are products that can slow the process or ease the symptoms.




ZYTO Announces Discussions Regarding Possible Sale of Health & Wellness Business, Pivot into Solar Energy Business

Mon, 16 Jan 2017 23:20:58 EST

LINDON, UT--(Marketwired - January 16, 2017) - ZYTO Corp (OTC PINK: ZYTO) (www.ZYTO.com).




ZYTO Announces New Chief Executive Officer

Mon, 16 Jan 2017 23:02:16 EST

LINDON, UT--(Marketwired - January 16, 2017) - ZYTO Corp (OTC PINK: ZYTO) (www.ZYTO.com).




Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs

Mon, 16 Jan 2017 09:00:00 EST

LAS VEGAS, NV--(Marketwired - Jan 16, 2017) - Health Advance Inc. (the "Company") (OTC PINK: HADV) is pleased to announce that the Company has closed the Share Exchange Agreement ("Agreement") to acquire Hantian Labs Limited, a private UK corporation (Hereinafter referred to as "Hantian"). As a result of the acquisition, Health Advance will also control 99% of JT Hantian LLC representing the revenue arm of Hantian. Pursuant to the Agreement, the Company has issued 18,000,000 common shares of the Company to the shareholders of Hantian Labs representing the purchase price of Hantian. Accordingly, the Company's issued and outstanding number of common shares increased from 26,520,000 shares to 44,520,000 shares. In addition, Company has waived Hantian's undertaking to raise a minimum financing of $250,000 for marketing of Hantian's product line prior to closing.




Namaste Purchases VaporSeller Earn-Out

Mon, 16 Jan 2017 08:18:04 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 16, 2017) - Namaste Technologies Inc. ("Namaste") (CSE:N)(CSE:N.CN)(FRANKFURT:M5BQ) is pleased to announce that it has entered into a binding amending agreement (the "Amending Agreement") with Haze Industries, Inc. ("Haze") for the purchase of the remaining earn-out obligation as set forth in the definitive asset purchase agreement (the "Asset Purchase Agreement") announced on June 7, 2016. The Asset Purchase Agreement memorialized the terms and conditions whereby Namaste purchased the assets comprising VaporSeller, an e-commerce platform for the distribution of vaporizers and accessories that is focused on the US market and generated an unaudited revenue of US$3.4 million in 2015. The initial undiscounted value of the earn-out was approximately US$1.5 million. Namaste will settle the remaining earn-out obligation of approximately US$1.3 million by making an initial payment of US$285,000 and monthly payments of US$8,000 for 12-months. Namaste will also issue Haze the initial tranche of 1,700,000 common shares of the Company pursuant to the Asset Purchase Agreement. The total number of shares to be issued is 5,000,000, as previously announced. All common shares issued will be subject to a 4-month statutory hold period.